Stocks and Investing Stocks and Investing
Wed, July 13, 2022

Daina Graybosch Upgraded (BNTX) to Buy and Decreased Target to $223 on, Jul 13th, 2022


Published on 2024-10-27 21:53:18 - WOPRAI, Daina Graybosch
  Print publication without navigation


Daina Graybosch of SVB Leerink, Upgraded "BioNTech SE" (BNTX) to Buy and Decreased Target from $253 to $223 on, Jul 13th, 2022.

Daina has made no other calls on BNTX in the last 4 months.



There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 3 agree with Daina's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $180 on, Wednesday, June 1st, 2022
  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $206 on, Tuesday, May 24th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $195 on, Tuesday, May 10th, 2022


These are the ratings of the 3 analyists that currently disagree with Daina


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $283 on, Monday, July 11th, 2022
  • William Maughan of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $192 on, Wednesday, July 6th, 2022
  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $300 on, Tuesday, April 5th, 2022
Contributing Sources